The Windshire Group Launches Stabilityshire(SM)
New Service Offering Helps Pharmaceutical Companies Outsource Stability Data Analysis, Reporting, and Management
(firmenpresse) - NEEDHAM, MA -- (Marketwired) -- 09/04/15 -- The Windshire Group, LLC, a global consulting group providing comprehensive consulting services to biopharmaceutical, pharmaceutical, medical device, and cell therapy companies, and industry investors, today announced the launch of Stabilityshire(SM), a drug stability and shelf-life data analysis, assessment, reporting, and management service. The service allows organizations to supplement internal capabilities or to completely outsource their stability data management and analysis requirements, while accessing world-class expertise.
The Stabilityshire service evaluates stability data to determine the appropriate shelf-life for new drugs and to monitor ongoing stability performance. The service is fully compliant and based on a cGMP quality system, and uses fully validated trend analysis software that is compliant with cGMP, ISO and ICH Q1E requirements. It produces stability reports, including trend analysis, and provides authorship of the stability sections of regulatory submissions -- such as INDs, IMPDs, and NDAs. The service can manage entire stability programs, including outsourcing and stability testing at CROs and CMOs. For current or ongoing stability programs, Stabilityshire can also assess these for cGMP and ICH compliance.
"We have been very pleased with our clients'' response to the Stabilityshire service offering," said James Blackwell, Ph.D., President and Principal Consultant, The Windshire Group. "It is an excellent complement to our comprehensive consulting services and increases our ability to meet our clients'' drug development and compliance needs. It also fits our long term strategy to offer industry leading comprehensive data analysis and management services, such as our ProcessPad™ offering for ongoing process and manufacturing data analysis and verification."
The Windshire Group serves biopharmaceutical and pharmaceutical clients globally by providing technical, regulatory, quality, and strategic expertise. Together with strategic partners, the consultancy can seamlessly address comprehensive client process and product development and manufacturing needs. By melding technical excellence and vast pharmaceutical industry experience with best business practices, The Windshire Group delivers exemplary results. Windshire consultants are located throughout North America and Eurasia. To learn more about about Stabilityshire(SM), ProcessPad(SM), or The Windshire Group, visit or contact the Company at 844.686.5750 or .
Contact:
James Blackwell
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 04.09.2015 - 12:24 Uhr
Sprache: Deutsch
News-ID 1383510
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
NEEDHAM, MA
Phone:
Kategorie:
Medical Devices
Anmerkungen:
Diese Pressemitteilung wurde bisher 167 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"The Windshire Group Launches Stabilityshire(SM)
"
steht unter der journalistisch-redaktionellen Verantwortung von
The Windshire Group (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
